$4.14
0.00%
Nasdaq, Sep 18, 04:00 pm EDT. Closed.
ISIN
CA27966L1085
Symbol
EDSA

Edesa Biotech Inc Stock price

$4.14
-1.57 27.50% 1M
-3.55 46.16% 6M
+2.72 191.55% YTD
+1.84 80.00% 1Y
-1.95 32.02% 3Y
-79.30 95.04% 5Y
-845.52 99.51% 10Y
-585.92 99.30% 20Y
Nasdaq, Closing price Fri, Sep 18 2026
+0.00 0.00%
ISIN
CA27966L1085
Symbol
EDSA
Industry

Is Edesa Biotech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$55.9m
Enterprise Value
$45.6m
Net debt
positive
Cash
$10.3m
Shares outstanding
9.6m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
6.4
Financial Health
Equity Ratio
92.0%
Return on Equity
-
ROCE
-166.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-14.6m
EBIT
$-14.6m
Net Income
$-14.1m
Free Cash Flow
$-8.9m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-130.6%
EBIT
-126.9%
Net Income
-138.2%
Free Cash Flow
-35.6%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-1.6
FCF per Share
$-0.9
Short interest
2.8%
Employees
17
Rev per Employee
-

Edesa Biotech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Edesa Biotech Inc forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Edesa Biotech Inc forecast:

Buy
89%
Hold
11%

Financial data from Edesa Biotech Inc

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.55 5.55
42% 42%
-
- Research and Development Expense 9.08 9.08
256% 256%
-
-15 -15
131% 131%
-
- Depreciation and Amortization 0.08 0.08
43% 43%
-
EBIT (Operating Income) EBIT -15 -15
127% 127%
-
Net Profit -14 -14
138% 138%
-

In millions USD.

Don't miss a Thing! We will send you all news about Edesa Biotech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Edesa Biotech Inc Stock News

Neutral
GlobeNewsWire
about one month ago
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the pricing of an underwritten public offering consisting of (i) 3,870,500 common shares and accompanying common share warrants to purchase an aggreg...
Neutral
GlobeNewsWire
about one month ago
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that it has commenced an underwritten public offering of its common shares (or pre-funded warrants to purchase common shares in lieu thereof) and acc...
Neutral
GlobeNewsWire
about one month ago
TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2026 and provided an update on its business.
More Edesa Biotech Inc News

Company Profile

Edesa Biotech, Inc. is a biopharmaceutical company. It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company product candidate, EB01, is a sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded in 2007 and is headquartered in Markham, Canada.

Head office Canada
CEO Dr. Nijhawan
Employees 17
Founded 2007
Website www.edesabiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today